Clinical Trials
6 trialsNCT06451497 2026-04-02
This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors
Zumutor Biologics Inc.
Phase 1 Recruiting
NCT00145626 2017-06-19
HLA-Nonidentical Stem Cell and Natural Killer Cell Transplantation for Children Less the Two Years of Age With Hematologic Malignancies
St. Jude Children's Research Hospital
Phase 2 Completed
NCT00145613 2009-02-13
Haploidentical Stem Cell Transplant for Treatment Refractory Hematological Malignancies
St. Jude Children's Research Hospital
Phase 2 Completed
NCT00143559 2009-01-29
Stem Cell Transplantation as Immunotherapy for Hematologic Malignancies
St. Jude Children's Research Hospital
Phase 2 Completed
NCT00152139 2009-01-29
Stem Cell Transplantation for Patients With Hematologic Malignancies
St. Jude Children's Research Hospital
Phase 3 Completed
NCT00186823 2009-01-29
Haploidentical Stem Cell Transplantation for Patients With Hematologic Malignancies
St. Jude Children's Research Hospital
Phase 3 Completed